Outsourced Pharma Capacity Update Videos - Large Molecule
-
Northway Biotech Capacity Update April 2025: Large Molecule Development
4/22/2025
Detra Glinatsis, Vice President of Business Development, presents the advanced capabilities, strategic growth, and expanding capacity of Northway Biotech, a global biologics CDMO.
-
Abzena Capacity Update April 2025: Large Molecule Development
4/22/2025
See first-hand how AbZelectPRO™, an evolved approach to cell line development, can simplify selection, enhance stability, and de-risk your program for faster regulatory approval.
-
Curia Capacity Update April 2025: Large Molecule Development
4/22/2025
Site head Bill Hermans showcases our facility's specialized capabilities in Hopkinton, Massachusetts, and shares how our team serves as a true scientific partner to clients.
-
Cytovance Biologics Capacity Update April 2025: Large Molecule Development
4/22/2025
Speed up your program with end-to-end microbial and mammalian biologics development and manufacturing expertise — spanning everything from biosimilars to vaccines.
-
Novartis Capacity Update April 2025: Large Molecule Development
4/22/2025
Experience a global network of expertise and proven manufacturing capabilities that can help accelerate your clinical and commercial drug substance programs.
-
Samsung Biologics Capacity Update April 2025: Large Molecule Development
4/22/2025
Leveraging advanced technology, expertise, and flexible capacity, clients can reduce development time and costs while ensuring a smooth transition from clinical to commercial manufacturing.
-
Boehringer Ingelheim Capacity Update April 2025: Large Molecule Development
4/22/2025
Explore how world-class contract manufacturing expertise and global capabilities can help accelerate your biologic from development to commercial success.
-
Catalent Capacity Update April 2025: Large Molecule Development
4/22/2025
By leveraging our proprietary non-viral gene insertion technology, GPEx® Lightning ensures rapid development timelines and high-yield production, making it an ideal solution for complex biologics.
-
FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Large Molecule Development
4/22/2025
Associate Director kojoX and Technology Development, Rasmus Petersen, presents a high-level overview of FDB’s capabilities, its global facilities network, and capacity updates for BIOLOGICS.
-
Northway Biotech Capacity Update January 2025: Large Molecule Development
1/28/2025
Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction.